| | | | | |
ANIK Anika Therapeutics Inc | $21,4000 | +0,28% | $294,82M | $10,68K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4850 | -0,24% | $294,73M | $321,00 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,0750 | +0,25% | $294,68M | $5,000 | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $42,6700 | +0,52% | $294,53M | $3,21K | |
| $43,5100 | +0,37% | $294,35M | $5,80K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $10,0200 | +0,20% | $294,35M | $41,00 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0800 | +0,00% | $294,33M | $9,000 | |
SLN Silence Therapeutics Plc American Depository Share | $13,2340 | +0,49% | $294,27M | $17,85K | |
MTNE CH4 Natural Solutions Corporation | $9,9000 | +0,10% | $293,88M | $5,000 | |
RXST RxSight, Inc. Common Stock | $6,0650 | -0,41% | $293,64M | $57,84K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,6450 | +0,33% | $293,52M | $9,92K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0250 | +0,00% | $293,49M | $39,00 | |
CNXU Conexeu Sciences Inc. Common Stock | $9,9560 | +5,58% | $293,27M | $80,38K | |
| $10,4740 | -1,10% | $292,98M | $212,53K | |
JCE Nuveen Core Equity Alpha Fund | $16,9060 | -0,38% | $292,78M | $12,16K | |
